|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 2401 to 2500 out of 2902 for Pdx1

<< First    < Previous  |  Next >    Last >>
0.04s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
23076356 | J:189216
First Author: Chugh R
Year: 2012
Journal: Sci Transl Med
Title: A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
Volume: 4
Issue: 156
Pages: 156ra139
•
•
•
•
•
Publication
26172047 | J:238533
First Author: Greco SH
Year: 2015
Journal: PLoS One
Title: TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
Volume: 10
Issue: 7
Pages: e0132786
•
•
•
•
•
Publication
29414775 | J:262781
First Author: Maity G
Year: 2018
Journal: J Biol Chem
Title: The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Volume: 293
Issue: 12
Pages: 4334-4349
•
•
•
•
•
Publication
29567829 | J:260710
First Author: Pushalkar S
Year: 2018
Journal: Cancer Discov
Title: The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.
Volume: 8
Issue: 4
Pages: 403-416
•
•
•
•
•
Publication
25557080 | J:219289
First Author: Boj SF
Year: 2015
Journal: Cell
Title: Organoid models of human and mouse ductal pancreatic cancer.
Volume: 160
Issue: 1-2
Pages: 324-38
•
•
•
•
•
Publication
27829137 | J:251957
First Author: Flint TR
Year: 2016
Journal: Cell Metab
Title: Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.
Volume: 24
Issue: 5
Pages: 672-684
•
•
•
•
•
Publication
23887057 | J:202529
First Author: Shen R
Year: 2013
Journal: Cancer Lett
Title: The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Volume: 339
Issue: 1
Pages: 135-43
•
•
•
•
•
Publication
26216548 | J:225891
First Author: Li T
Year: 2015
Journal: Cancer Res
Title: Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer.
Volume: 75
Issue: 18
Pages: 3738-46
•
•
•
•
•
Publication
24607504 | J:232076
First Author: Keenan BP
Year: 2014
Journal: Gastroenterology
Title: A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
Volume: 146
Issue: 7
Pages: 1784-94.e6
•
•
•
•
•
Publication
23689354 | J:200524
First Author: Li H
Year: 2013
Journal: Carcinogenesis
Title: Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
Volume: 34
Issue: 9
Pages: 2090-8
•
•
•
•
•
Publication
31413817 | J:317025
First Author: Strand MS
Year: 2019
Journal: Oncotarget
Title: Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles.
Volume: 10
Issue: 46
Pages: 4761-4775
•
•
•
•
•
Publication
26077591 | J:233548
First Author: Miller BW
Year: 2015
Journal: EMBO Mol Med
Title: Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.
Volume: 7
Issue: 8
Pages: 1063-76
•
•
•
•
•
Publication
29621546 | J:271449
First Author: Cao XY
Year: 2018
Journal: Biochem Biophys Res Commun
Title: Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Volume: 499
Issue: 3
Pages: 584-593
•
•
•
•
•
Publication
30154150 | J:266836
First Author: Nagathihalli NS
Year: 2018
Journal: Cancer Res
Title: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Volume: 78
Issue: 21
Pages: 6235-6246
•
•
•
•
•
Publication
25584895 | J:219808
First Author: Wong PP
Year: 2015
Journal: Cancer Cell
Title: Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.
Volume: 27
Issue: 1
Pages: 123-37
•
•
•
•
•
Publication
33110235 | J:301792
First Author: Nimmakayala RK
Year: 2021
Journal: Oncogene
Title: Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Volume: 40
Issue: 1
Pages: 215-231
•
•
•
•
•
Publication
31439856 | J:306897
First Author: Filippini D
Year: 2019
Journal: Sci Rep
Title: Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease.
Volume: 9
Issue: 1
Pages: 12286
•
•
•
•
•
Publication
35561453 | J:325347
 
First Author: Jiang SH
Year: 2022
Journal: EBioMedicine
Title: Modeling of cancer-related body-wide effects identifies LTB4 as a diagnostic biomarker for pancreatic cancer.
Volume: 80
Pages: 104050
•
•
•
•
•
Publication
31397499 | J:298216
First Author: Xu D
Year: 2019
Journal: Mol Carcinog
Title: Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53.
Volume: 58
Issue: 11
Pages: 2052-2064
•
•
•
•
•
Publication
29259015 | J:261887
First Author: Dauer P
Year: 2018
Journal: Cancer Res
Title: Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.
Volume: 78
Issue: 5
Pages: 1321-1333
•
•
•
•
•
Publication
26310823 | J:224975
 
First Author: Schneider P
Year: 2015
Journal: Nat Commun
Title: Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.
Volume: 6
Pages: 8023
•
•
•
•
•
Publication
30052815 | J:265576
First Author: Dugnani E
Year: 2018
Journal: Carcinogenesis
Title: Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound.
Volume: 39
Issue: 9
Pages: 1197-1206
•
•
•
•
•
Publication
30990168 | J:275210
   
First Author: Sullivan MR
Year: 2019
Journal: Elife
Title: Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability.
Volume: 8
•
•
•
•
•
Publication
26893480 | J:231693
First Author: Hein AL
Year: 2016
Journal: Cancer Res
Title: PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling.
Volume: 76
Issue: 8
Pages: 2243-2253
•
•
•
•
•
Publication
31527715 | J:306834
First Author: Parameswaran N
Year: 2019
Journal: Sci Rep
Title: A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas.
Volume: 9
Issue: 1
Pages: 13396
•
•
•
•
•
Publication
26144316 | J:224529
First Author: Palm W
Year: 2015
Journal: Cell
Title: The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1.
Volume: 162
Issue: 2
Pages: 259-270
•
•
•
•
•
Publication
28453537 | J:245950
First Author: Kersemans V
Year: 2017
Journal: PLoS One
Title: An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouse.
Volume: 12
Issue: 4
Pages: e0176693
•
•
•
•
•
Publication
32580961 | J:296304
First Author: Wang F
Year: 2020
Journal: Cancer Res
Title: p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis.
Volume: 80
Issue: 16
Pages: 3251-3264
•
•
•
•
•
Publication
30538117 | J:269591
 
First Author: Cortes E
Year: 2019
Journal: EMBO Rep
Title: GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment.
Volume: 20
Issue: 1
•
•
•
•
•
Publication
31369062 | J:290838
First Author: Mendez R
Year: 2020
Journal: Carcinogenesis
Title: Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.
Volume: 41
Issue: 5
Pages: 561-570
•
•
•
•
•
Publication
29135982 | J:252226
First Author: Baird JR
Year: 2017
Journal: PLoS One
Title: STING expression and response to treatment with STING ligands in premalignant and malignant disease.
Volume: 12
Issue: 11
Pages: e0187532
•
•
•
•
•
Publication
22585996 | J:193075
First Author: Frese KK
Year: 2012
Journal: Cancer Discov
Title: nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.
Volume: 2
Issue: 3
Pages: 260-269
•
•
•
•
•
Publication
37190324 | J:335631
 
First Author: Yang D
Year: 2023
Journal: Cancers (Basel)
Title: Cross-Dataset Single-Cell Analysis Identifies Temporal Alterations in Cell Populations of Primary Pancreatic Tumor and Liver Metastasis.
Volume: 15
Issue: 8
•
•
•
•
•
Publication
28315323 | J:325940
First Author: Jiang SH
Year: 2017
Journal: Gastroenterology
Title: Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Volume: 153
Issue: 1
Pages: 277-291.e19
•
•
•
•
•
Publication
37445930 | J:337929
 
First Author: Cortez NE
Year: 2023
Journal: Int J Mol Sci
Title: A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice.
Volume: 24
Issue: 13
•
•
•
•
•
Publication
28024083 | J:254380
First Author: Davidson SM
Year: 2017
Journal: Nat Med
Title: Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.
Volume: 23
Issue: 2
Pages: 235-241
•
•
•
•
•
Publication
23963802 | J:303013
First Author: Husain K
Year: 2013
Journal: Cancer Prev Res (Phila)
Title: Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.
Volume: 6
Issue: 10
Pages: 1074-83
•
•
•
•
•
Publication
27919787 | J:239396
 
First Author: Garg B
Year: 2017
Journal: Cancer Lett
Title: Modulation of post-translational modifications in β-catenin and LRP6 inhibits Wnt signaling pathway in pancreatic cancer.
Volume: 388
Pages: 64-72
•
•
•
•
•
Publication
31662451 | J:284232
First Author: Dey S
Year: 2020
Journal: Mol Cancer Res
Title: miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2.
Volume: 18
Issue: 2
Pages: 311-323
•
•
•
•
•
Publication
21403843 | J:171634
First Author: Fendrich V
Year: 2011
Journal: Neoplasia
Title: Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
Volume: 13
Issue: 2
Pages: 180-6
•
•
•
•
•
Publication
27489361 | J:236853
First Author: Grünwald B
Year: 2016
Journal: Mol Cancer Res
Title: Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow.
Volume: 14
Issue: 11
Pages: 1147-1158
•
•
•
•
•
Publication
30863319 | J:309716
 
First Author: Li C
Year: 2019
Journal: Front Physiol
Title: MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).
Volume: 10
Pages: 147
•
•
•
•
•
Publication
19460966 | J:149213
First Author: Olive KP
Year: 2009
Journal: Science
Title: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
Volume: 324
Issue: 5933
Pages: 1457-61
•
•
•
•
•
Publication
23840665 | J:203716
First Author: Courtin A
Year: 2013
Journal: PLoS One
Title: Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer.
Volume: 8
Issue: 6
Pages: e67330
•
•
•
•
•
Publication
29237705 | J:257588
First Author: Deng YZ
Year: 2018
Journal: J Exp Med
Title: Cilia loss sensitizes cells to transformation by activating the mevalonate pathway.
Volume: 215
Issue: 1
Pages: 177-195
•
•
•
•
•
Publication
21242978 | J:173715
First Author: Shields DJ
Year: 2011
Journal: Oncogene
Title: Oncogenic Ras/Src cooperativity in pancreatic neoplasia.
Volume: 30
Issue: 18
Pages: 2123-34
•
•
•
•
•
Publication
26977883 | J:231763
First Author: Wei D
Year: 2016
Journal: Cancer Cell
Title: KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis.
Volume: 29
Issue: 3
Pages: 324-38
•
•
•
•
•
Publication
29367759 | J:261029
First Author: Fendrich V
Year: 2018
Journal: Oncogene
Title: Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
Volume: 37
Issue: 14
Pages: 1845-1856
•
•
•
•
•
Publication
34345207 | J:336894
First Author: Jia Y
Year: 2021
Journal: Int J Biol Sci
Title: Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development.
Volume: 17
Issue: 11
Pages: 2772-2794
•
•
•
•
•
Publication
25629724 | J:219792
 
First Author: Schlomann U
Year: 2015
Journal: Nat Commun
Title: ADAM8 as a drug target in pancreatic cancer.
Volume: 6
Pages: 6175
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S4/SvJae * C57BL/6 * ICR
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a<+> Kras/Kras<+> Smad4/Smad4 Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Smad4/Smad4 Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a<+> Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S4/SvJae * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ctnnb1/Ctnnb1 Tg(Pdx1-cre)6Tuv/?
Background: involves: 129P2/OlaHsd * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras Tg(Pdx1-cre/Esr1*)35.10Dam/?
Background: involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras Trim33/Trim33 Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Sox17/Sox17 Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Wls/Wls Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S/SvEv * FVB/N * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S4/SvJae * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Tg(Pdx1-cre)89.1Dam/? Trp53/Trp53
Background: involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53<+>
Background: involves: 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Brca2/Brca2<+> Kras/Kras<+> Trp53/Trp53<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Brca2/Brca2<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Brca2/Brca2 Tg(Pdx1-cre)6Tuv/? Trp53/Trp53<+>
Background: involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Brca2/Brca2 Tg(Pdx1-cre)6Tuv/?
Background: involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Trp53/Trp53<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S4/SvJaeSor * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a<+> Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Trp53/Trp53 Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129 * C57BL/6 * CBA * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Trp53/Trp53<+> Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129 * C57BL/6 * CBA * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129 * C57BL/6 * CBA * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Usp9x/?
Background: involves: 129S4/SvJae * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Usp9x/Usp9x<+>
Background: involves: 129S4/SvJae * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S4/SvJae * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129P2/OlaHsd * 129S4/SvJae * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Brca1/Brca1 Kras/Kras<+> Trp53/Trp53 Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Trp53/Trp53 Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S4/SvJae * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Tg(CAG-Bgeo,-tsA58T)T26Ichi/? Tg(Pdx1-cre)6Tuv/?
Background: involves: 129P2/OlaHsd * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdh1/Cdh1<+> Smad4/Smad4 Trp53/Trp53 Tg(Pdx1-cre)6Tuv/?
Background: involves: 129 * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdh1/Cdh1 Smad4/Smad4 Trp53/Trp53 Tg(Pdx1-cre)6Tuv/?
Background: involves: 129 * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Sox17/Sox17<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Pdx1/Pdx1<+> Trp53/Trp53<+>
Background: involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * Black Swiss * C57BL/6
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Pdx1/Pdx1<+> Trp53/Trp53
Background: involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * Black Swiss * C57BL/6
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Hprt1/Hprt1<+> Kras/Kras<+> Trp53/Trp53<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Brf1/Brf1 Kras/Kras<+> Trp53/Trp53<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S4/SvJae * 129S7/SvEvBrd * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53<+>
Background: involves: 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Tg(Pdx1-cre)6Tuv/?
Background: involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Rr124128/Rr124128 Tg(Pdx1-cre)6Tuv/?
Background: involves: C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: 2610035D17Rik/2610035D17Rik Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/? Trp53/Trp53<+>
Background: involves: C57BL/6JGpt * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Jag1/Jag1 Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Dicer1/Dicer1<+> Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129 * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Dicer1/Dicer1 Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129 * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Tg(CAG-lacZ,-Akt1*,-EGFP)56Ebm/? Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pdx1-cre)1Herr/?
Background: involves: 129S4/SvJaeSor * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Tg(CAG-Bgeo/GFP)21Lbe/? Tg(Pdx1-cre)89.1Dam/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom